Response Pharmaceuticals’ drug has helped reduce the amount of weight a patient regains after treatment with glucagon-like ...

In this randomized, double-blind trial, Aligos Therapeutics is evaluating its investigational oral capsid assembly modulator ALG-000184 against tenofovir disoproxil fumarate in 200 treatment-naïve ...

The trial aims to compare the efficacy and safety of the therapy as a single agent with tenofovir disoproxil fumarate.

Enrollment is complete for a Phase 2 trial testing Zenas Biopharma's obexelimab in relapsing MS, with results expected later ...

Vedanta is parting ways with 23 employees, or approximately 20% of its headcount, after Phase II data for microbiome therapy ...

Panama City officials announced on Monday that construction is officially underway for a new portion in Phase 2 of the ...

Kansas athletic director Travis Goff explained how David Booth’s donation gives the Jayhawks more confidence for phase two of ...

"Vendanta’s culls UC microbiome therapy on Phase II fail" was originally created and published by Clinical Trials Arena, a ...

The study tests BNT327, an investigational drug administered via intravenous infusion, in combination with standard chemotherapy drugs like etoposide, carboplatin, paclitaxel, and topotecan. The goal ...